PEGylated Proteins Market - Analysis, Technologies & Forecasts to 2021 - Key Vendors are Biomatrik, Celares GmbH & Merck Millipore - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "PEGylated Proteins Market - Global Forecast to 2021" report to their offering.

The global PEGylated proteins market is expected to surpass $1.1 billion by 2021, growing at a CAGR of 10.5% between 2016 and 2021.

The growth of this market is mainly driven by increase in R&D spending of pharmaceutical & biotechnology companies, growth in biologics sector, high prevalence of lifestyle disease, and increase in adoption of protein based drugs over non-protein based drugs. In addition, rising opportunities in emerging markets, and top-selling biologics drugs going off-patent in the near future provides a growing opportunity to this market.

This report segments the global PEGylated proteins market by product, protein type, application and end-user. By product, the market includes consumables and services. Based on protein type, the market is segmented into colony stimulating factors, interferons, erythropoietin, mAbs, and recombinant factor VIII. The colony stimulating factors segment will hold the largest share of the PEGylated proteins type market in 2016.

The geographic segments included in this report are North America, Europe, Asia, and Rest of the World (RoW). North America is expected to account for the largest share in the global the PEGylated proteins market in 2016. Asia is expected to register the fastest growth in the forecast period.

Companies Mentioned:

  • Biomatrik, Inc.
  • Celares GmbH
  • Creative Pegworks
  • Iris Biotech GmbH
  • Jenkem Technology
  • Laysan Bio, Inc.
  • Merck Millipore
  • NOF American Corporation (A Subsidiary of NOF Corporation)
  • Quanta Biodesign, Ltd
  • Thermo Fisher Scientific Inc.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Industry Insights

6 Market Overview

7 PEGylated Proteins Market, By Product

8 PEGylated Proteins Market, By Protein Type

9 PEGylated Proteins Market, By Application

10 End-User Market, By End-User

11 PEGylated Proteins Market, By Region

12 Competitive Landscape

13 Company Profiles

14 Appendix

For more information about this report visit http://www.researchandmarkets.com/research/9xdmv5/pegylated

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Drug Discovery

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Drug Discovery